Arch Therapeutics logo

ARTH Arch Therapeutics

Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development and provision of hemostasis and sealant technology platform. Its product candidates include AC5 Devices, which designed to achieve hemostasis during surgical, wound, and interventional care. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.

Healthcare Biotechnology SIC: Unknown CIK: 1537561 Auditor raised Going Concern issues

Login to follow ARTH

Transaction DateRecipientSharesTypePriceValue
Jodie Insights Rating